252 related articles for article (PubMed ID: 20060302)
21. Water molecules as structural determinants among prions of low sequence identity.
De Simone A; Dodson GG; Fraternali F; Zagari A
FEBS Lett; 2006 May; 580(10):2488-94. PubMed ID: 16638576
[TBL] [Abstract][Full Text] [Related]
22. The conversion of helix H2 to beta-sheet is accelerated in the monomer and dimer of the prion protein upon T183A mutation.
Chebaro Y; Derreumaux P
J Phys Chem B; 2009 May; 113(19):6942-8. PubMed ID: 19371053
[TBL] [Abstract][Full Text] [Related]
23. Toward a mechanism of prion misfolding and structural models of PrP(Sc): current knowledge and future directions.
Guest WC; Plotkin SS; Cashman NR
J Toxicol Environ Health A; 2011; 74(2-4):154-60. PubMed ID: 21218344
[TBL] [Abstract][Full Text] [Related]
24. Transmissible spongiform encephalopathies.
Liemann S; Glockshuber R
Biochem Biophys Res Commun; 1998 Sep; 250(2):187-93. PubMed ID: 9753605
[TBL] [Abstract][Full Text] [Related]
25. [Prion protein structure and its relationships with pathogenesis].
Muramoto T
Rinsho Shinkeigaku; 2003 Nov; 43(11):813-6. PubMed ID: 15152472
[TBL] [Abstract][Full Text] [Related]
26. Inhibition of prion propagation in scrapie-infected mouse neuroblastoma cell lines using mouse monoclonal antibodies against prion protein.
Miyamoto K; Nakamura N; Aosasa M; Nishida N; Yokoyama T; Horiuchi H; Furusawa S; Matsuda H
Biochem Biophys Res Commun; 2005 Sep; 335(1):197-204. PubMed ID: 16061207
[TBL] [Abstract][Full Text] [Related]
27. X-ray diffraction of scrapie prion rods and PrP peptides.
Nguyen JT; Inouye H; Baldwin MA; Fletterick RJ; Cohen FE; Prusiner SB; Kirschner DA
J Mol Biol; 1995 Sep; 252(4):412-22. PubMed ID: 7563061
[TBL] [Abstract][Full Text] [Related]
28. Disparate evolution of prion protein domains and the distinct origin of Doppel- and prion-related loci revealed by fish-to-mammal comparisons.
Rivera-Milla E; Oidtmann B; Panagiotidis CH; Baier M; Sklaviadis T; Hoffmann R; Zhou Y; Solis GP; Stuermer CA; Málaga-Trillo E
FASEB J; 2006 Feb; 20(2):317-9. PubMed ID: 16352647
[TBL] [Abstract][Full Text] [Related]
29. Chaperonin-mediated de novo generation of prion protein aggregates.
Stöckel J; Hartl FU
J Mol Biol; 2001 Nov; 313(4):861-72. PubMed ID: 11697909
[TBL] [Abstract][Full Text] [Related]
30. Exploring the propensities of helices in PrP(C) to form beta sheet using NMR structures and sequence alignments.
Dima RI; Thirumalai D
Biophys J; 2002 Sep; 83(3):1268-80. PubMed ID: 12202354
[TBL] [Abstract][Full Text] [Related]
31. Exploring structural and thermodynamic stabilities of human prion protein pathogenic mutants D202N, E211Q and Q217R.
Guo J; Ren H; Ning L; Liu H; Yao X
J Struct Biol; 2012 Jun; 178(3):225-32. PubMed ID: 22491059
[TBL] [Abstract][Full Text] [Related]
32. Probing the N-terminal β-sheet conversion in the crystal structure of the human prion protein bound to a nanobody.
Abskharon RN; Giachin G; Wohlkonig A; Soror SH; Pardon E; Legname G; Steyaert J
J Am Chem Soc; 2014 Jan; 136(3):937-44. PubMed ID: 24400836
[TBL] [Abstract][Full Text] [Related]
33. Ser170 controls the conformational multiplicity of the loop 166-175 in prion proteins: implication for conversion and species barrier.
Gorfe AA; Caflisch A
FASEB J; 2007 Oct; 21(12):3279-87. PubMed ID: 17522379
[TBL] [Abstract][Full Text] [Related]
34. Mammalian prions: tolerance to sequence changes-how far?
Salamat MK; Munoz-Montesino C; Moudjou M; Rezaei H; Laude H; Béringue V; Dron M
Prion; 2013; 7(2):131-5. PubMed ID: 23232499
[TBL] [Abstract][Full Text] [Related]
35. Hot spot of structural ambivalence in prion protein revealed by secondary structure principal component analysis.
Yamamoto N
J Phys Chem B; 2014 Aug; 118(33):9826-33. PubMed ID: 25101991
[TBL] [Abstract][Full Text] [Related]
36. Beta-sheet core of human prion protein amyloid fibrils as determined by hydrogen/deuterium exchange.
Lu X; Wintrode PL; Surewicz WK
Proc Natl Acad Sci U S A; 2007 Jan; 104(5):1510-5. PubMed ID: 17242357
[TBL] [Abstract][Full Text] [Related]
37. The oligomerization properties of prion protein are restricted to the H2H3 domain.
Chakroun N; Prigent S; Dreiss CA; Noinville S; Chapuis C; Fraternali F; Rezaei H
FASEB J; 2010 Sep; 24(9):3222-31. PubMed ID: 20410442
[TBL] [Abstract][Full Text] [Related]
38. The role of prion peptide structure and aggregation in toxicity and membrane binding.
Rymer DL; Good TA
J Neurochem; 2000 Dec; 75(6):2536-45. PubMed ID: 11080207
[TBL] [Abstract][Full Text] [Related]
39. Constant-pH molecular dynamics simulations reveal a β-rich form of the human prion protein.
Campos SR; Machuqueiro M; Baptista AM
J Phys Chem B; 2010 Oct; 114(39):12692-700. PubMed ID: 20843095
[TBL] [Abstract][Full Text] [Related]
40. Parallel in-register intermolecular β-sheet architectures for prion-seeded prion protein (PrP) amyloids.
Groveman BR; Dolan MA; Taubner LM; Kraus A; Wickner RB; Caughey B
J Biol Chem; 2014 Aug; 289(35):24129-42. PubMed ID: 25028516
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
